跳至主要内容
临床试验/IRCT2016111529812N2
IRCT2016111529812N2已完成未知

The effect of oral N-acetyl cystein on inflammatory markers in hemodialysis patients

Vice Chancellor for research of University of Medical Sciences and Health Services, Yazd0 个研究点目标入组 26 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Inclusion critera: patients undergone hemodialysis that received hemodialysis for more than 3 month with 3 sessions per week. Exclusion criteria: Patients undergone hemodialysis with venous catheter; symptoms of active infection in one month before starting the study and during the study; rising liver enzymes(ALT and AST); blood transfusion during the study; collagen vascular diseases were the etiology of end stage renal disease; age lesser than 18 –year- old, use of corticosteroid and immunosuppressive drugs; history of myocardial infarction or stroke in 3 month before starting the study; history of intolerance or allergy to NAC.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of University of Medical Sciences and Health Services, Yazd

相似试验